Carbogen Amcis' Indian subsidiary will open a high potency facility on the Bavla site of its parent company, Dishman Pharmaceuticals & Chemicals Ltd. The 4300m3 facility, which is expected to be operational by Q1 2009, will include four segregated high potency cells with reactor sizes ranging from 630L to 1600L and a number of contained development laboratories.
Carbogen Amcis
Friday, 4 April 2008
Carbogen adds high potency in India
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment